Immunotherapy: Open Access
Open Access

Lung Cancer Immunotherapy

Lung Cancer Immunotherapy is broadly divided into four main categories which includes Checkpoint inhibitors, Therapeutic vaccines, Monoclonal antibodies and T cell transfer. Checkpoint Inhibitors serve as checks and balances in the regulation of immune responses.

Therapeutic vaccines target tumor or shared -specific antigens. Monoclonal antibodies (mAbs) are molecules target specific antigens on tumors. In T cell transfer activity of T- cells is enhanced by modification or treatment with chemicals. They are modified with goal to improve immune system response against cancer.

Related Journals of Lung Cancer Immunotherapy

Immunotherapy: Open Access, Immunology Journal, Immunobiology journal, Immunome Research journal, Immunooncology journal, ATS Journals, Journal of Thoracic Disease, Clinical Medicine and Research, Frontiers in Oncology, Future Oncology.